TLR4 and osteoarthritis: To confirm the anti-inflammatory potentials of Lupeol, a study was performed where the activation of inflammatory markers toll-like receptor-4 (TLR4) and NF-κB were found in an osteoarthritis rat model, while Lupeol treatment attenuated these inflammatory agents and exhibited its anti-inflammatory effects [83].